Table 1.
Wilcoxon Signed Ranks Test | Z | p |
---|---|---|
Control group native phase HU—tumor group native HU | −2.462 | 0.014 |
Control group arterial phase HU—tumor group arterial HU | −1.045 | 0.296 |
Control group venous phase HU—tumor group venous HU | −2.800 | 0.005 |
Control group delayed phase HU—tumor group delayed HU | −3.664 | 0.000 |
99mTc-HYNIC-TOC target/non-target ratio | −6.154 | 0.000 |